• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MIO¿ ADVANCE; UNO MIO ADV. GREY 60/6 SC1 10-PK INT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MIO¿ ADVANCE; UNO MIO ADV. GREY 60/6 SC1 10-PK INT Back to Search Results
Lot Number UNKNOWN
Device Problem Infusion or Flow Problem (2964)
Patient Problem Diabetic Ketoacidosis (2364)
Event Type  Injury  
Event Description
Unomedical reference number (b)(4).Event occurred in the united states.On (b)(6) 2024, the patient reported that she faced an occlusion alarm and changed the infusion set on wednesday, then again on thursday, but same day (on thursday) her blood glucose level kept going up.Therefore, she went to the hospital on (b)(6) 2024 (friday) at 9:20 am due to high blood glucose level of 600 mg/dl.Currently, her blood glucose level was 214 mg/dl.During hospitalization, the patient received intravenous drip as corrective treatment.At the time of this report, the patient still in the hospital.No further information was available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MIO¿ ADVANCE
Type of Device
UNO MIO ADV. GREY 60/6 SC1 10-PK INT
Manufacturer Contact
aaholmvej 1-3
osted
lejre, 4320
MDR Report Key18756292
MDR Text Key335932252
Report Number8021545-2024-00114
Device Sequence Number1
Product Code FPA
Combination Product (y/n)Y
PMA/PMN Number
K173879
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 02/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Lot NumberUNKNOWN
Initial Date Manufacturer Received 02/19/2024
Initial Date FDA Received02/22/2024
Patient Sequence Number1
-
-